Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.
News Menu



Fri, Feb 22nd, 2019
Oncopeptides AB: Year-end Report 2018

STOCKHOLM , Feb. 22, 2019 /PRNewswire/ -- Summary of Q4

Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

Alimentation Couche-Tard and Canopy Growth join forces to launch a premium cannabis retail brand in London, Ontario

LAVAL , QC and SMITHS FALLS, ON , Feb. 21, 2019 /PRNewswire/ - Alimentation Couche-Tard Inc. ("Alimentation-Couche-Tard") (TSX: ATD.A) (TSX: ATD.B) has entered into a multi-year agreement with...

CGC : 45.04 (-2.66%)
WEED.TO : 59.41 (-2.29%)
Boston Scientific Prices $4.3 Billion of Senior Notes

MARLBOROUGH, Mass. , Feb. 21, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $4.3 billion aggregate principal amount of its senior...

BSX : 40.12 (+0.02%)
Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award

HOUSTON , Feb. 21, 2019 /PRNewswire/ --  Marker Therapeutics, Inc.  (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies...

MRKR : 5.91 (-2.64%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corporation - CVS

NEW YORK , Feb. 21, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or the "Company") (NYSE:  CVS).  Such investors are advised...

CVS : 62.35 (-2.91%)
Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study

ENGLEWOOD CLIFFS, N.J. , Feb. 21, 2019 /PRNewswire/ -- Enzychem Lifesciences, Corp. (KOSDAQ: 183490) announced today that the company has achieved a huge milestone by completing enrollment of the...

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2018 on Thursday, February 28, 2019, After Close of U.S.-Based Financial Markets

SAN FRANCISCO , Feb. 21, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2018 , on Thursday,...

NKTR : 40.26 (-6.44%)
Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2018

MECHANICSBURG, Pa. , Feb. 21, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31,...

SEM : 15.48 (-0.83%)
Marvell Announces Appointment of Sandeep Bharathi as Senior Vice President of Central Engineering

SANTA CLARA, Calif. , Feb. 21, 2019 /PRNewswire/ -- Marvell Technology Group Ltd. (NASDAQ: MRVL), a leader in infrastructure semiconductor solutions, is pleased to announce that Sandeep Bharathi...

RIGL : 2.36 (+0.43%)
MRVL : 19.61 (-0.96%)
Total 2018 revenue increased 71 percent to $454 million, and 934,000 people were screened with Cologuard

MADISON, Wis. , Feb. 21, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $454.5 million and completed approximately 934,000 Cologuard...

EXAS : 83.28 (-0.42%)
BioMarin Announces Full Year and Fourth Quarter 2018 Results

SAN RAFAEL, Calif. , Feb. 21, 2019 /PRNewswire/ --

BMRN : 88.81 (-2.04%)
NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference

SAN DIEGO , Feb. 21, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally...

NUVA : 57.27 (+3.34%)
Array BioPharma to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

BOULDER, Colo. , Feb. 21, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer , will speak at the SVB Leerink Partners 8 ...

ARRY : 22.71 (-1.99%)
Halozyme Reports Fourth Quarter And Full-Year 2018 Results

SAN DIEGO , Feb. 21, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today reported financial results...

HALO : 16.61 (-1.54%)
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast

SGMO : 8.54 (+0.95%)
Natural Alternatives International Appoints New Sports Nutrition Business Development Manager for CarnoSyn® Brands

CARLSBAD, Calif. , Feb. 21, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) is pleased to announce and welcome David Brook as Sports Nutrition Business Development...

NAII : 11.22 (+1.45%)
AbbVie Declares Quarterly Dividend

NORTH CHICAGO, Ill. , Feb. 21, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE:ABBV) declared a quarterly cash dividend of $1.07 per share. The cash dividend is payable May...

ABBV : 78.75 (-1.55%)
Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year

BARCELONA, Spain , Feb. 21, 2019 /PRNewswire/ -- Grifols has earned the honor of 2019 Category Leader in IV Workflow Management in the 2019 Best in KLAS: Software & Services report for its...

GRFS : 18.98 (-2.62%)
GIKLY : 12.8500 (-4.10%)
New Real-World Evidence Analysis of Nearly Half a Million FreeStyle® Libre System Users Shows Higher Rates of Scanning Improves Glucose Control

BERLIN , Feb. 21, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from three real-world evidence studies that provide a comprehensive look at the global use of the FreeStyle ® ...

ABT : 75.14 (-0.53%)

Chart of the Day

Workiva Llc (WK)

The Barchart Chart of the Day belongs to the Internet software company Workiva (WK). I found the stock by using Barchart to sort the New All Time High list first by the highest Weighted Alpha, then used the Flipchart feature to review the charts fo...
Read More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar